ClinicalTrials.govrestricted
Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal
ClinicalTrials.gov study NCT01915108. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4